{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T11:57:04Z","timestamp":1794916624751,"version":"4.9.1"},"reference-count":41,"publisher":"BMJ","issue":"5","funder":[{"DOI":"10.13039\/501100000805","name":"European Centre for Disease Prevention and Control","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000805","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010677","name":"H2020 Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2018,8,20]]},"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Pneumococcal conjugate vaccines (PCVs) have the potential to prevent pneumococcal disease through direct and indirect protection. This multicentre European study estimated the indirect effects of 5-year childhood PCV10 and\/or PCV13 programmes on invasive pneumococcal disease (IPD) in older adults across 13 sites in 10 European countries, to support decision-making on pneumococcal vaccination policies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>For each site we calculated IPD incidence rate ratios (IRR) in people aged \u226565\u2009years by serotype for each PCV10\/13\u2009year (2011\u20132015) compared with 2009 (pre-PCV10\/13). We calculated pooled IRR and 95% CI using random-effects meta-analysis and PCV10\/13 effect as (1 \u2212 IRR)*100.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>After five PCV10\/13 years, the incidence of IPD caused by all types, PCV7 and additional PCV13 serotypes declined 9% (95% CI \u22124% to 19%), 77% (95% CI 67% to 84%) and 38% (95% CI 19% to 53%), respectively, while the incidence of non-PCV13 serotypes increased 63% (95% CI 39% to 91%). The incidence of serotypes included in PCV13 and not in PCV10 decreased 37% (95% CI 22% to 50%) in six PCV13 sites and increased by 50% (95% CI \u22128% to 146%) in the four sites using PCV10 (alone or with PCV13). In 2015, PCV13 serotypes represented 20\u201329%\u2009and 32\u201353% of IPD cases in PCV13 and PCV10 sites, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Overall IPD incidence in older adults decreased moderately after five childhood PCV10\/13 years in 13 European sites. Large declines in PCV10\/13 serotype IPD, due to the indirect effect of childhood vaccination, were countered by increases in non-PCV13 IPD, but these declines varied according to the childhood vaccine used. Decision-making on pneumococcal vaccination for older adults must consider the indirect effects of childhood PCV programmes. Sustained monitoring of IPD epidemiology is imperative.<\/jats:p><\/jats:sec>","DOI":"10.1136\/thoraxjnl-2018-211767","type":"journal-article","created":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T16:19:45Z","timestamp":1540397985000},"page":"473-482","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":161,"title":["Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination"],"prefix":"10.1136","volume":"74","author":[{"given":"Germaine","family":"Hanquet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavla","family":"Krizova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palle","family":"Valentiner-Branth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamez N","family":"Ladhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Pekka","family":"Nuorti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Lepoutre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolita","family":"Mereckiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Knol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brita A","family":"Winje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Ciruela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ordobas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Guevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisin","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Morfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Kozakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Christian","family":"Slotved","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman K","family":"Fry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Rinta-Kokko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Varon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Corcoran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie","family":"van der Ende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didrik F","family":"Vestrheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Munoz-Almagro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pello","family":"Latasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Castilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitta","family":"Henriques-Normark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Whittaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Pastore Celentano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camelia","family":"Savulescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,10,24]]},"reference":[{"key":"2024092104351371000_74.5.473.1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043619","article-title":"Epidemiology of invasive pneumococcal disease in older people in Spain (2007-2009): implications for future vaccination strategies","volume":"7","author":"Ardanuy","year":"2012","journal-title":"PLoS One"},{"key":"2024092104351371000_74.5.473.2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2807\/1560-7917.ES2014.19.31.20869","article-title":"Epidemiology and outcome of invasive pneumococcal disease among adults in Belgium, 2009-2011","volume":"19","author":"Verhaegen","year":"2014","journal-title":"Euro Surveill"},{"key":"2024092104351371000_74.5.473.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2005.01282.x"},{"key":"2024092104351371000_74.5.473.4","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12461"},{"key":"2024092104351371000_74.5.473.5","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix685"},{"key":"2024092104351371000_74.5.473.6","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-014-2208-6"},{"key":"2024092104351371000_74.5.473.7","unstructured":"European Medicines Agency (EMA). European Public Assessment Report (EPAR) for Prevenar 13. ANNEX I. Summary of product characteristics . London: EMA, 2015."},{"key":"2024092104351371000_74.5.473.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.03.054"},{"key":"2024092104351371000_74.5.473.9","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01451-2015"},{"key":"2024092104351371000_74.5.473.10","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)70044-7"},{"key":"2024092104351371000_74.5.473.11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu524"},{"key":"2024092104351371000_74.5.473.12","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)71081-3"},{"key":"2024092104351371000_74.5.473.13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169368","article-title":"Effectiveness of the 23-valent pneumococcal polysaccharide vaccine (PPV23) against pneumococcal disease in the elderly: systematic review and meta-analysis","volume":"12","author":"Falkenhorst","year":"2017","journal-title":"PLoS One"},{"key":"2024092104351371000_74.5.473.14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000422.pub2"},{"key":"2024092104351371000_74.5.473.15","unstructured":"European Commission. COMMISSION IMPLEMENTING DECISION of 8 August 2012 amending Decision 2002\/253\/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119\/98\/EC of the European Parliament and of the Council. 2012\/506\/EU. Official Journal of the European Union 2012."},{"key":"2024092104351371000_74.5.473.16","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009196"},{"key":"2024092104351371000_74.5.473.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.07.006"},{"key":"2024092104351371000_74.5.473.18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131117","article-title":"The Czech surveillance system for invasive pneumococcal disease, 2008-2013: a follow-up assessment and sensitivity estimation","volume":"10","author":"Stock","year":"2015","journal-title":"PLoS One"},{"key":"2024092104351371000_74.5.473.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.11.011"},{"key":"2024092104351371000_74.5.473.20","unstructured":"Dorl\u00e9ans F , M\u00f8lbak F , Voldstedlund M , et al . Evaluating the completeness of the invasive pneumococcal diseases surveillance system in Denmark, 2010\u20132011. European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE). Stockholm: ECDC, 2013."},{"key":"2024092104351371000_74.5.473.21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d549"},{"key":"2024092104351371000_74.5.473.22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-8-79"},{"key":"2024092104351371000_74.5.473.23","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/S2214-109X(16)30306-0","article-title":"Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis","volume":"5","author":"Shiri","year":"2017","journal-title":"Lancet Glob Health"},{"issue":"4 Suppl 1","key":"2024092104351371000_74.5.473.24","first-page":"134","article-title":"Invasive pneumococcal disease in children and adults in seven Italian regions after the introduction of the conjugate vaccine, 2008-2014","volume":"39","author":"D\u2019Ancona","year":"2015","journal-title":"Epidemiol Prev"},{"key":"2024092104351371000_74.5.473.25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131494","article-title":"Effects of infant pneumococcal conjugate vaccination on serotype distribution in invasive pneumococcal disease among children and adults in Germany","volume":"10","author":"van der Linden","year":"2015","journal-title":"PLoS One"},{"key":"2024092104351371000_74.5.473.26","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70090-1"},{"key":"2024092104351371000_74.5.473.27","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S1473-3099(11)70143-8","article-title":"Assessing the effect of pneumococcal conjugate vaccines: what is the value of routinely collected surveillance data?","volume":"11","author":"Grijalva","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"2024092104351371000_74.5.473.28","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1586\/14760584.2015.1075884","article-title":"The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on serotype 19A invasive pneumococcal disease","volume":"14","author":"Principi","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"2024092104351371000_74.5.473.29","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1016\/j.vaccine.2015.10.007","article-title":"Indirect cohort analysis of 10-valent pneumococcal conjugate vaccine effectiveness against vaccine-type and vaccine-related invasive pneumococcal disease","volume":"33","author":"Verani","year":"2015","journal-title":"Vaccine"},{"key":"2024092104351371000_74.5.473.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.11.060"},{"key":"2024092104351371000_74.5.473.31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.epidem.2015.01.001","article-title":"Pneumococcal vaccination in older adults in the era of childhood vaccination: public health insights from a Norwegian statistical prediction study","volume":"11","author":"Steens","year":"2015","journal-title":"Epidemics"},{"key":"2024092104351371000_74.5.473.32","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1017\/S0950268817001194","article-title":"The epidemiology of invasive pneumococcal disease in older adults in the post-PCV era. Has there been a herd effect?","volume":"145","author":"Corcoran","year":"2017","journal-title":"Epidemiol Infect"},{"key":"2024092104351371000_74.5.473.33","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3201\/eid2301.160897","article-title":"Increased invasive pneumococcal disease, North East England, UK","volume":"23","author":"Houseman","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"2024092104351371000_74.5.473.34","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30052-5"},{"key":"2024092104351371000_74.5.473.35","doi-asserted-by":"publisher","DOI":"10.1086\/323339"},{"key":"2024092104351371000_74.5.473.36","doi-asserted-by":"publisher","DOI":"10.1086\/649872"},{"key":"2024092104351371000_74.5.473.37","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268803001511"},{"key":"2024092104351371000_74.5.473.38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1651-2227.2000.tb00778.x","article-title":"Epidemiology of meningitis and bacteraemia due to Streptococcus pneumoniae in The Netherlands","volume":"89","author":"Spanjaard","year":"2000","journal-title":"Acta Paediatr Suppl"},{"key":"2024092104351371000_74.5.473.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.12.054"},{"key":"2024092104351371000_74.5.473.40","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu213"},{"key":"2024092104351371000_74.5.473.41","doi-asserted-by":"crossref","first-page":"19868","DOI":"10.2807\/ese.16.20.19868-en","article-title":"Long term trends introduce a potential bias when evaluating the impact of the pneumococcal conjugate vaccination programme in England and Wales","volume":"16","author":"Flasche","year":"2011","journal-title":"Euro Surveill"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thoraxjnl-2018-211767","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T11:36:35Z","timestamp":1726918595000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thoraxjnl-2018-211767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,24]]},"references-count":41,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,4,11]]},"published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.1136\/thoraxjnl-2018-211767"],"URL":"https:\/\/doi.org\/10.1136\/thoraxjnl-2018-211767","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,24]]}}}